ERMA Enorama Pharma AB (publ)
Enorama Pharma AB (publ), a pharmaceutical company, develops, manufactures, and sells tobacco-free white snus in Sweden. It offers its products under the NIC-S brand name. The company was incorporated in 2006 and is based in Stockholm, Sweden.…
Industry Peers
Drug Manufacturers - Specialty & GenericKey Statistics
About Enorama Pharma (STO: ERMA)
›
Enorama Pharma (STO: ERMA) is listed on Nasdaq Stockholm, where its shares trade in SEK. It belongs to the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector, and reports about 4 employees.
The shares were at 0.5160 SEK on 19 November 2026, down 80.5% over 52 weeks. Its 52-week range is 0.2110 SEK to 2.860 SEK: the price is 82.0% below the high and 144.5% above the low.
Its market capitalisation is 38.49M SEK.
Enorama Pharma reports return on equity of 320.4% and revenue down 81.5% year over year.
It holds more cash than debt, a net cash position of 2.10M SEK. Its Piotroski F-score is 1 out of 9, a weak reading of its financial health.